SCHEMBL29515462

SCHEMBL29515462

Cc1cccc(C)c1-c1nc(N)nc(O)c1C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 4/20 0.36
▸ ADORA1 P30542 3/20 0.35
▸ PDK2 Q15119 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HSP90AA1 P07900 3/20 0.34
▸ HSP90AB1 P08238 1/20 0.34
▸ NUDT1 P36639 1/20 0.33
▸ GABRA1 P14867 1/20 0.33
▸ GABRB2 P47870 1/20 0.33
▸ TRPA1 O75762 2/20 0.32
▸ ATM Q13315 1/20 0.32
▸ DHFR P00374 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ SRC P12931 1/20 0.32
▸ PTPN1 P18031 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29515297 0.86 HSP90AA1 (0.37) ADORA2AADORA1HSP90AA1HSP90AB1PTPN1
SCHEMBL29515208 0.82 PTPN1 (0.32) ADORA2AADORA1HSP90AA1HSP90AB1PTPN1
SCHEMBL24331938 0.82 PTPN1 (0.32) ADORA2AADORA1HSP90AA1HSP90AB1PTPN1
SCHEMBL26870483 0.77 TRPA1 (0.35) PDK2HSP90AA1NUDT1TRPA1ATM
SCHEMBL29515123 0.71 ADORA2B (0.36) ADORA2AALDH1A1HSP90AA1HSP90AB1NUDT1
SCHEMBL24332015 0.71 ADORA2B (0.36) ADORA2AALDH1A1HSP90AA1HSP90AB1NUDT1
SCHEMBL26688117 0.68 ADORA2A (0.39) ADORA2AADORA1ALDH1A1HSP90AA1HSP90AB1
SCHEMBL29515168 0.68 ADORA2A (0.39) ADORA2AADORA1ALDH1A1HSP90AA1HSP90AB1
SCHEMBL24331365 0.66 HSP90AA1 (0.41) ADORA2AADORA1HSP90AA1SRC
SCHEMBL24310408 0.65 KDM4E (0.32) ALDH1A1HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225761-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076620-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback